Main > INFECTIOUS DISEASES > HelicoBacter Pylori Infection > (GastroEnterology). Vaccines > Patent > Literature. > Helicobacter pylori Bacteria > Strain NB3-2 (ATCC 55714) or > G1-4 (ATCC 55713). > In-Vitro Culture Medium Conditions > Bile Acid. Bile Salts (0.025-0.6%) > GlycoCholate or Bile (0.05-0.15%) > Temp. = 30 - 42C (i.e. 37C) > in Gas Mixt. = Air (80-90%) & CO2 > (10-20%). > Divalent Cation Chelator Selected > 1,2-Bis(2-AminoPhenoxy)Ethane-N,N,N > ,N-TetraAcetic Acid/AcetoxyMe Ester > Culture: Early Log Phase > Anti-Helicobacter Ab Production > Method: Immunizing with Immunogen > Comprising Helicobacter Bacterium > Immune Response Stimulation > Administering Immunogen Comprising > Helicobacter Bacterium. > Patent Assignee
Patent Assignee's products
USA. A